01 27AbbVie Inc
02 1Douglas CDMO
03 62care4
04 12Accord healthcare
05 2Altan Pharma
06 6Amneal Pharmaceuticals
07 3Ascent Innovative Medicines
08 6Aurobindo Pharma Limited
09 2Aurovitas Spain, Sau
10 2Biem Ilac San. ve Tic. A.S
11 3Bionpharma
12 3Caplin Point Laboratories Limited
13 3Chartwell Pharmaceuticals llc
14 1Cinfa
15 1Ebb Medical
16 1Epic Pharma. LLC.
17 4Farbe Firma
18 2Farmatek
19 3Hikma Pharmaceuticals
20 3Hospira, Inc.
21 3LABORATORIOS NORMON SA
22 3Lotus Pharmaceutical
23 3Marksans Pharma
24 2Nobel Ilac Sanayii Ve Ticaret A.S.
25 10ORIFARM GROUP AS
26 1Paranova Pharmaceuticals Ab
27 2Pharmada Pharmaceuticals
28 6Pharmathen SA
29 2Polifarma
30 6Rising Pharmaceuticals Inc
31 1STADA Arzneimittel
32 5Sandoz B2B
33 2Sun Pharmaceutical Industries Limited
34 11Teva Pharmaceutical Industries
35 2Unimedic AB
36 2Viatris
37 1Vir Sa Chemical And Pharmaceutical Industry
01 2Ampule
02 27CAPSULE;ORAL
03 22Capsule
04 3INJECTABLE; INJECTION
05 2IV Solution for Injection
06 16Injectable Solution
07 4Injection
08 2Injection Solution
09 2Paracalcitolo 1Mcg 28 Combined Oral Use
10 2Paracalcitolo 2Mcg 28 Combined Oral Use
11 1Paracalcitolo 5Mcg 1 Unit Parenteral Use
12 4Paracalcitolo 5Mcg 5 Units Parenteral Use
13 1SOFT GEL CAPSULES
14 28SOLUTION;INTRAVENOUS
15 14Soft Capsule
16 2Soft Capsules
17 3Soft Gel
18 12Solution For Injection
19 2Solution for I.V. Injection
20 4Solution for Injection
01 5Allowed
02 5Approved
03 19Authorized
04 3Cancelled
05 16DISCN
06 15Deregistered
07 4EU Approved
08 1Generic
09 2Marketed
10 3Not Marketed
11 3Prescription
12 39RX
13 2Withdrawn
14 36Blank
01 2Calsipar
02 1MYLAN CALCITOLO
03 1PARACALCITOL SANDZ
04 2PARACALCITOLO TEVA ITALY
05 52PARICALCITOL
06 5Paracalcitolo
07 2Paricalcitol
08 2Paricalcitol 2Care4
09 4Paricalcitol Accord
10 2Paricalcitol Accordpharma
11 2Paricalcitol Altan
12 5Paricalcitol Alternova
13 1Paricalcitol Aurovitas
14 1Paricalcitol Aurovitas Spain
15 1Paricalcitol Cinfa
16 1Paricalcitol Ebb
17 3Paricalcitol Normon
18 1Paricalcitol Stada
19 2Paricalcitol Sun
20 1Paricalcitol Teva
21 2Paricalcitol "Pharmathen"
22 2Pariquel
23 2Parisitol
24 1Pleopar
25 9ZEMPLAR
26 25Zemplar
27 2Zemplar ?g
28 3Zemplar ugml
29 16Blank
01 3Denmark
02 4Greece
03 7India
04 16Italy
05 2Malta
06 1New Zealand
07 5Norway
08 22Spain
09 20Sweden
10 5Switzerland
11 10Turkey
12 58USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ZEMPLAR
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.005MG/ML (0.005MG/ML)
Packaging :
Approval Date : 1998-04-17
Application Number : 20819
Regulatory Info : RX
Registration Country : USA
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : SOFT GEL CAPSULES
Dosage Strength : 1.2MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
Regulatory Info : RX
Registration Country : USA
Brand Name : ZEMPLAR
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.002MG/ML (0.002MG/ML)
Packaging :
Approval Date : 2000-02-01
Application Number : 20819
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ZEMPLAR
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.01MG/2ML (0.005MG/ML)
Packaging :
Approval Date : 2000-02-01
Application Number : 20819
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZEMPLAR
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MCG
Packaging :
Approval Date : 2005-05-26
Application Number : 21606
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ZEMPLAR
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MCG
Packaging :
Approval Date : 2005-05-26
Application Number : 21606
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ZEMPLAR
Dosage Form : CAPSULE;ORAL
Dosage Strength : 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-05-26
Application Number : 21606
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Zemplar
Dosage Form : Paracalcitolo 1Mcg 28 Combined Oral Use
Dosage Strength : 28 cps molli 1 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Zemplar
Dosage Form : Paracalcitolo 2Mcg 28 Combined Oral Use
Dosage Strength : 28 cps molli 2 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Zemplar
Dosage Form : Paracalcitolo 5Mcg 5 Units Parenteral Use
Dosage Strength : 5 ampoules 1 ml 5 mcg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Zemplar
Dosage Form : Paracalcitolo 5Mcg 5 Units Parenteral Use
Dosage Strength : 5 vials 1 ml 5 mcg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : ZEMPLAR
Dosage Form : Soft Capsule
Dosage Strength : 1 microgram
Packaging : 28 UNIT 1 MCG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : ZEMPLAR
Dosage Form : Soft Capsules
Dosage Strength : 2 micrograms
Packaging : 28 UNIT 2 MCG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : ZEMPLAR
Dosage Form : Solution For Injection
Dosage Strength : 5 mcg/ml
Packaging : 5 UNIT 5 MCG - PARENTERAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Zemplar ugml
Dosage Form : Solution For Injection
Dosage Strength : 5mcg/ml
Packaging :
Approval Date : 09/08/2004
Application Number : 56312
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Zemplar ugml
Dosage Form : Solution For Injection
Dosage Strength : 10mcg/2ml
Packaging :
Approval Date : 09/08/2004
Application Number : 56312
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Zemplar ugml
Dosage Form : Solution For Injection
Dosage Strength : 2mcg/ml
Packaging :
Approval Date : 09/08/2004
Application Number : 56312
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Zemplar ?g
Dosage Form : Soft Capsule
Dosage Strength : 1mcg
Packaging :
Approval Date : 12/03/2008
Application Number : 57989
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Zemplar ?g
Dosage Form : Soft Capsule
Dosage Strength : 2mcg
Packaging :
Approval Date : 12/03/2008
Application Number : 57989
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Zemplar
Dosage Form : Injectable Solution
Dosage Strength : 2MCG
Packaging :
Approval Date : 17-01-2007
Application Number : 68362
Regulatory Info : Cancelled
Registration Country : Spain
